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The purpose of this study was to evaluate gene expression profiles in the liver and blood for prediction of infection severity from Listeria
monocytogenes (LM). Mice were injected with medium broth (control) or a nonlethal or lethal dose of LM and sacrificed 6 h later. Gene
expression changes were determined using Affymetrix MGU74Av2 GeneChips and confirmed by real-time polymerase chain reaction
analysis. We identified discernable genes whose gene expression profiles can be used in pattern recognition to predict and classify samples in
differently treated groups, with 90% accuracy in liver samples and 80% accuracy in blood at prediction; however, different genes were
predictive in each tissue. Our results suggest that gene expression profiling in response to LM in mice may be able to distinguish samples in
groups with varying severity of infection and provide information in finding molecular mechanisms and early biomarkers for subsequent
conventional clinical endpoints.
D 2005 Elsevier Inc. All rights reserved.Keywords: Listeria monocytogenes; Gene expression profiling; Microarray; Class prediction; BiomarkerThere is a tremendous need for research studies on
pathogen-induced characteristics in host gene expression,
with the ultimate goal being the design and development of
assays that can rapidly identify and diagnose pathogen
exposure before the onset of overt clinical symptoms. We
chose Listeria monocytogenes (LM) as a model infectious
agent because it is a food-borne pathogen that affects
pregnant women, newborns, and immunocompromised
adults. Listeriosis has been recognized as an important public
health problem in the United States [1]. The systemic
infection of mice with LM is also a widely used model to
study mammalian host defense response to intracellular
bacterial pathogens [2] and to examine immunotoxic effects
of therapeutics [3].
LM is an intracellular gram-positive pathogen [2].
Immediately after systemic infection, most bacteria are0888-7543/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: hanna.ng@sri.com (H.H. Ng).cleared rapidly from the bloodstream and can be recovered
in the liver 10 min after infection [4]. The vast majority of
microorganisms are entrapped in the liver and destroyed
there by phagocytes and neutrophils [2,4]. The listerial
burden in the liver increases exponentially after 6 h,
reaching a plateau between days 3 and 4 and then declining
with an increase in specific immunity [5]. The LM
bacterium utilizes the host’s cellular processes to affect
cell-to-cell interactions, move intracellularly, and proliferate
[6]. Much of this is accomplished through pathogen-induced
alterations in host cell signal transduction [7] and by
utilizing the host cell’s actin-based cytoskeleton [6]. While
LM is a well-studied model, the effects of LM on host gene
expression remain largely unknown. Characterization of the
LM-induced alterations in mouse gene expression will
provide mechanistic information on the disease process
and yield biomarkers of clinical disease.
Advances in microarray technology have enabled mas-
sive parallel mining of gene expression data by measuring
the hybridization of mRNA to thousands of specific cDNA05) 657 – 667
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‘‘chip’’ that are complementary to known genes or expressed
sequence tags (ESTs). Microarrays provide a sensitive and
high-throughput tool that can be applied to many areas,
including cancer research, molecular and cell biology,
physiology, pharmacology, toxicology, and risk assessment
[8–12]. Using microarrays, multiple genes have been
identified that have altered gene expression in response to
chemical exposure in cell culture [13] and in animals [14–
16]. Gene transcription profiles have been proposed to be
useful in discriminating samples exposed to different classes
of toxicants and predicting toxicity of unknown or similar
compounds [17]. In addition, analyzing gene expression
patterns across the tumor tissues of individual patients
demonstrated the potential of refinement or confirmation in
cancer classification that provides better prognostication and
treatment selection [18–24]. Thus, expression profiling may
classify and predict phenotypes of toxicity in response to
bioagents or chemical exposures.
Infection bymicroorganisms leads to a series of changes in
the physiology of host cells. Many changes are relayed by
signal transduction systems and are expressed by alterations
in the transcription levels of host genes. Numerous studies
using microarray technology have shown that infectious
microorganisms, including human immunodeficiency virus 1
[25], simian immunodeficiency virus [26], herpes simplex
virus 1 [27], adenovirus [28],Coxiella burnetii or Chlamydia
trachomatis [29], Mycobacterium tuberculosis [30,31],
Salmonella [32], and the protozoan kinetoplastid parasite
Trypanosoma cruzi [33], induce differential gene expression
in host target cells during the course of infection. However,
most reported microarray studies have centered on primary
cells or cultured cell lines. Few examples [26,31,33] have
described the host response to systemic infection with virus,
bacteria, and protozoans in vivo. To our knowledge this is the
first report of microarray gene expression studies in host
response to LM.
Since gene expression responses to infectious agents
begin to take place within the first few hours after
exposure, gene expression profiling will be useful in
diagnosing pathogen exposure in advance of clinical
symptoms, allowing exposed individuals to be rapidly
triaged for treatment. Our goal is to characterize the
changes in gene expression in female BALB/c mice 6 h
after infection with LM and evaluate the gene expression
profiling in the liver and blood for prediction of clinical
outcomes.Fig. 1. Recovery of LM from the liver after injection with medium broth
(control), nonlethal dose, and lethal dose. There was no detectable LM in
the livers from control animals. Animals in the lethal high-dose group were
found dead on day 3 or were severely moribund and therefore sacrificed.
No data were obtained for the lethal group on days 4, 14, and 21. N = 3
animals per sex at each time point.Results
Infectious burden, histopathology, and clinical pathology
evaluation
Female BALB/c mice were administered, via intravenous
tail injection, medium broth (control) or 9.8  102 colonyforming units (CFU) (nonlethal dose) or 5.3  104 CFU
(lethal dose) of LM. The LM replicated rapidly in the liver,
reaching a plateau between days 1 and 2 (Fig. 1). Then the
infectious burden in the mice infected with the nonlethal dose
gradually declined, clearing by day 21. LM burden data are
not available for the lethal group on days 4, 14, and 21
because there were no survivors in this group after day 3.
There was no detectable LM in the livers from control
(uninfected) animals.
Pathological evaluations of brain and liver that were
harvested at various times postinfection were performed on
animals receiving control broth, nonlethal dose, and lethal
dose of LM. The brains from all mice were histologically
normal. Ten percent of mice that received the nonlethal dose
and 100% mice that received the lethal dose had hepatic
inflammatory lesions (abscessation) characteristic of LM
infection (Fig. 2). In addition, significant increases in serum
aspartate aminotransferase and alanine aminotransferase,
which are markers of liver toxicity, were observed in the
lethal dose group (Table 1).
LM-induced gene expression changes in the host
Liver samples were processed for microassay gene
expression analysis; 31 GeneChips (9 from control animals,
13 from the nonlethal group, and 9 from the lethal group)
passed the quality checks after hybridization and scanning.
After normalization and filtering for gene quality control,
6227 genes were left for further evaluation. Since the
minimum change in differential expression that can be
accurately detected is 1.4-fold [34], we selected only those
genes for which differential expression changes were 1.5-
fold or greater and were statistically significant (one-way
ANOVA, p < 0.05). We found 53 genes in the nonlethal
group and 89 genes in the lethal group that had at least a
1.5-fold change in transcription level, compared with those
in the control group; 17 genes were significantly changed
in both the nonlethal and the lethal group, compared with
controls. These differentially expressed genes in the LM-
Fig. 2. Histopathology of panel A normal control liver tissue and panel B liver tissue from mouse with lethal infection with LM. In (A), the vein present in one
corner of the control is partially filled with erythrocytes. In (B), there are two foci of necrotic hepatic parenchyma containing myriad bacteria. The parenchyma
surrounding lesions is normal. Original magnification 100; hematoxylin and eosin stain.
H.H. Ng et al. / Genomics 86 (2005) 657–667 659infected animals are to be further studied to provide
mechanistic information on the disease process and
mammalian host defense response to intracellular bacterial
pathogens.
Sample prediction using LM-induced host gene expression
in liver
We sought to identify genes with a prediction rule to
classify samples into groups correlating with clinical
outcomes. Employing the GeneSpring software, we used
an approach similar to that of Golub et al. [20]. In our study,
21 liver gene expression profiles, 7 from each group
(control, nonlethal, lethal), were randomly selected in the
Training Set to build the model using the K-nearest-
neighbor algorithm to predict and classify the rest of 10
independent unknown samples according to their gene
expression profiles. Fifty genes were selected arbitrarily as
highly ranked predictive genes in the class prediction model.
In the prediction, 9 of the 10 test samples were correctly
predicted and 1 was incorrect in terms of infection severity.
Similar predictions with differently randomized samples in
the Training Set and Test Set were performed two more
times. Three sets of 50 arbitrary predictive genes wereTable 1
Clinical chemistry parameters: aspartate aminotransferase (AST) and
alanine aminotransferase (ALT)
Group AST (IU/L) ALT (IU/L)
Day 1 Day 2 Day 4 Day 14 Day 1 Day 2 Day 4 Day 14
Control 132 118 98 210 72 83 52 98
Nonlethal 199 138 152* 164 162* 115 117 67
Lethal 522* 8705* – – 339* 4609* – –
Blood was collected for clinical pathology from animals in each group on
different days postinfection. The number is an average of N = 6, except in
the lethal dose group on day 2, for which N = 4. One-way ANOVA
followed by Dunnett’s test was used to analyze differences between control
and nonlethal or lethal samples.
* p < 0.05 was considered statistically significant.generated. A small subset of 8 genes was identified to be
common in these three sets of 50 predictive genes. We used
the gene expression signature of this 8-gene set in all 31
samples to construct a hierarchical clustering according to
the expression similarities between samples. As shown in
Fig. 3, gene expression patterns were significantly associ-
ated with the treatment groups; animals in the same group as
control, nonlethal, or lethal clustered together.
We then used this subset of eight genes to predict
outcomes in the 10 Test samples, which randomized three
times from the 31 liver samples. As shown in Table 2, of
10 unknown Test samples, 9 or all 10 samples were
correctly predicted. The overall prediction accuracy was
90%. The sample (No. 30) that was predicted incorrectly
was an animal in the nonlethal group predicted to be a
control sample. This was consistent with the sample
clustering data (in Fig. 3, sample ‘‘30_liver nonlethal’’),
indicating that this animal may have been less responsive to
the infection.
The eight predictive genes included four upregulated
and four downregulated genes and were characterized with
regard to gene ontology classes according to the query
from the Affymetrix database as shown in Table 3. The
fold change of the gene represented a relative transcrip-
tional level in the treated animals compared with that in
controls.
Real-time RT-PCR for confirmation of expression change
Real-time RT-PCR was used to confirm the gene
expression fold changes generated by using microarray
analysis. Among the eight predictive genes in liver, we
chose two upregulated genes, T-cell-specific GTPase (Tgtp)
and serum amyloid A3 gene (Saa3), and one downregulated
gene, cytochrome P450, 17 (Cyp17a1). An internal control
(Gapdh, a housekeeping gene) was used as a baseline to
analyze the relative levels of Tgtp, Saa3, and Cyp17a1 in
RT-PCR. As shown in Table 3, the RT-PCR results support
the microarray-based observation of the fold change in gene
Fig. 3. Hierarchical clustering according to the similarities of the gene expression patterns for eight predictive genes between samples. Each row represents one
of the eight gene expressions and each column a separate sample. Animals 1–14 were in the control group, 18–31 were in the nonlethal group, and 35–48
were in the lethal group. A pseudo-colored representation of relative intensity is shown such that red indicates high expression and green low expression, with
scale shown at the right.
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animals relative to control animals.
Sample prediction using host gene expression profile in
blood in response to LM
We applied similar class prediction methods in the
analysis of 40 GeneChips that passed the initial quality
check from blood samples collected from the animals
treated with control, nonlethal, and lethal doses of LM as
follows: 14 from control, 13 from nonlethal, and 13 from
the lethal group. To build the model using the K-nearest-
neighbor algorithm to predict and classify unknown
samples, 30 gene expression profiles, 10 from each
group, were randomly selected in the Training Set.
Fourteen probes/genes were identified as high-ranking
predictive genes, in that 2 probes on the GeneChip
represent the same gene, Bcl2a1a (Table 4). We per-
formed three rounds of randomization using 40 Gene-Chips to assign 10 samples to the Test set. In each
prediction, 8 of 10 unknown Test samples were correctly
predicted (Table 5). The incorrectly predicted samples
were animals in the nonlethal dose group that were
predicted to be controls, suggesting less response to LM
infection in these animals.Discussion
The analysis of the interaction of pathogenic bacteria
with their host cell on the molecular and cellular levels has
become a major research area in recent years. Microarrays
provide the advantage of being able to investigate the
expression of thousands of genes, and bioinformatics
software offers an effective way of managing complex,
high-volume data and assisting in identifying patterns of
gene expression changes [35]. When we used hierarchical
cluster analysis to identify groups of samples related by
Table 2
Class prediction in three sets of randomized test samples from liver using the gene expression profiling for eight genes
Test 1 Test 2 Test 3
Sample True value Prediction Sample True value Prediction Sample True value Prediction
12_liver Control Control 18_liver Nonlethal Nonlethal 18_liver Nonlethal Nonlethal
14_liver Control Control 21_liver Nonlethal Nonlethal 19_liver Nonlethal Nonlethal
19_liver Nonlethal Nonlethal 23_liver Nonlethal Nonlethal 20_liver Nonlethal Nonlethal
27_liver Nonlethal Nonlethal 25_liver Nonlethal Nonlethal 24_liver Nonlethal Nonlethal
28_liver Nonlethal Nonlethal 28_liver Nonlethal Nonlethal 29_liver Nonlethal Nonlethal
29_liver Nonlethal Nonlethal 30_liver Nonlethal Controla 2_liver Control Control
30_liver Nonlethal Controla 36_liver Lethal Lethal 31_liver Nonlethal Nonlethal
31_liver Nonlethal Nonlethal 43_liver Lethal Lethal 35_liver Lethal Lethal
47_liver Lethal Lethal 5_liver Control Control 44_liver Lethal Lethal
48_liver Lethal Lethal 8_liver Control Control 9_liver Control Control
The true value refers to the known exposure, control, nonlethal, or lethal. The prediction value refers to the class to which the animal was predicted to belong,
based on the predictive gene set.
a Incorrect prediction.
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grouped in close proximity according to the control,
nonlethal, or lethal infected animals (Fig. 3). Data fromTable 3
Characterization of subset of eight predictive genes from liver with regard to ge
microarray and RT-PCR analysis
Probe
set ID
(Affymetrix)
Gene
name
Gene
symbol
Biological
process
description
Molec
functio
descrip
103334_at calcitonin
gene-related
peptide-receptor
component protein
Crcp Neuropeptide
signaling
pathway
101436_at chemokine
(C-X-C motif)
ligand 9
Cxcl9 Immune
response
Cytoki
activit
Inflammatory
response
Chemo
activit
102906_at T-cell-specific GTPase Tgtp GTP b
102416_at cytochrome P450,
family 17, subfamily a,
polypeptide 1
Cyp17a1 Electron
transport
Monoo
activit
C21-steroid
hormone
biosynthesis
Steroid
17-a-m
activit
Oxido
activit
104750_at Interferon-g-inducible
protein
Ifi47 Defense
response
104566_at argininosuccinate
lyase
Asl Arginine
catabolism
Lyase
Arginine
biosynthesis
Cataly
Urea cycle Argini
lyase a
96871_at RIKEN cDNA
2310042G06 gene
2310042G06Rik
102712_at serum amyloid A3 Saa3 Acute-phase
response
Lipid
activit
a Gene ontology information was derived from the Affymetrix NetAffx Analys
b Microarray data: fold change of gene expression level in treated groups relative
the gene is upregulated, and a number <1 means the gene is downregulated. N =
c RT-PCR analysis was performed for three genes: fold change of gene express
animals/group.this analysis demonstrated that gene expression in the host
response is remarkably homogeneous within the same group
but distinct from other groups. One outlier was animal 30,ne ontologya classes and relative gene expression level as determined by
ular
n
tion
Cellular
component
description
Gene expression
fold change
(microarray)b
Gene expression
fold change
(RT-PCR)c
Non-lethal Lethal Non-lethal Lethal
Acrosome 0.69 0.58 – –
ne
y
Extracellular
space
0.81 2.01 – –
kine
y
Extracellular
inding 1.04 3.43 1.40 3.31
xygenase
y
Mitochondrion 0.54 0.53 0.63 0.45
onooxygenase
y
Membrane
reductase
y
1.00 1.97 – –
activity Cytoplasm 0.58 0.44 – –
tic activity
nosuccinate
ctivity
0.69 0.71 – –
transporter
y
Extracellular
space
1.00 3.25 1.94 3.08
is Center.
to the control group value, which was normalized to 1. A number >1 means
9–13 animals/group.
ion level in treated groups is relative to the control group value. N = 3–4
Table 4
Characterization of subset of 14 predictive genes in blood with regard to gene ontologya classes and relative gene expression level in microarray
Probe
set ID
(Affymetrix)
Gene
name
Gene
symbol
Biological
process
description
Molecular
function
description
Cellular
component
description
Gene expression
fold change
(microarray)b
Non-lethal Lethal
100311_f_at eosinophil-associated,
ribonuclease
A family, member 1
Ear1 Nucleic acid binding,
nuclease activity,
endonuclease activity,
pancreatic ribonuclease
activity, hydrolase activity
Extracellular
space
2.61 5.25
100569_at annexin A2 Anxa2 Angiogenesis,
collagen
fibril organization,
fibrinolysis
Phospholipase inhibitor
activity, calcium ion
binding,
protein binding,
calcium-dependent
phospholipid binding,
cytoskeletal protein binding
Stress fiber,
membrane fraction,
cytoplasm, early
endosome,
cell junction
1.38 3.4
101571_g_at insulin-like growth
factor
binding protein 4
Igfbp4 Regulation of cell
growth
Insulin-like growth factor
binding,
growth factor binding
Extracellular,
extracellular space
3.47 3.23
102091_f_at 1.6 1.63
102914_s_at B-cell leukemia/
lymphoma 2-related
protein A1a, A1b,
A1c, A1d
Bcl2a1a,
Bcl2a1b,
Bcl2a1c,
Bcl2a1d
Apoptosis or
regulation
of apoptosis
1.91 2.51
103089_at CD48 antigen Cd48 Extracellular space,
plasma membrane
1.45 1.49
103240_f_at eosinophil-associated,
ribonuclease
A family, member 2
Ear2 Chemotaxis Nucleic acid binding,
nuclease activity,
endonuclease activity,
pancreatic ribonuclease
activity, hydrolase activity
1.66 2.65
103830_at snail homolog 1
(Drosophila)
Snai1 Development,
organogenesis
Nucleic acid binding,
DNA
binding,
zinc ion binding
Nucleus 0.66 0.57
104482_at epimorphin Epim Intracellular protein
transport
Protein transporter
activity
Membrane, integral
to membrane
0.84 0.72
162142_f_at proline-rich Gla
(G-carboxyglutamic acid)
polypeptide 2
Prrg2 Calcium ion binding,
protein binding
Extracellular region,
extracellular
space, integral to
membrane
0.65 0.79
93869_s_at B-cell leukemia/
lymphoma 2-related
protein A1a, A1c, A1d
Bcl2a1a,
Bcl2a1c,
Bcl2a1d
Apoptosis or
regulation
of apoptosis
1.29 2.08
94061_at cysteine-rich protein 1
(intestinal)
Crip1 Zinc ion binding 1.01 2.58
96522_at calmodulin 1 Calm1 Cell cycle,
G-protein-coupled
receptor protein
signaling pathway
Calcium ion binding,
protein
binding
Cytoplasm, plasma
membrane
1.42 1.79
98092_at placenta-specific 8 Plac8 1.55 2.5
a Gene ontology information was derived from the Affymetrix NetAffx Analysis Center.
b Fold change of gene expression level in treated groups relative to the control group value, which was normalized to 1. A number >1 means the gene is
upregulated, and a number <1 means the gene is downregulated. N = 13–14 animals/group.
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clustered with the control samples, indicating that this may
have been a less responsive animal. It also correlates with
the data in Table 2 in class prediction analysis that animal 30
was predicted as a control animal.
Fifty or as few as 8 genes with high-ranking scores
according to their significance for classification in the K-nearest-neighbor algorithm were identified to be able to
predict the animals treated with varying doses of LM. In
the 8-predictive gene set, 4 genes, including serum
amyloid A3 (Saa3), T-cell-specific GTPase (Tgtp), an
interferon (IFN)-g-inducible protein (Ifi47), and chemokine
(C-X-C motif) ligand 9 (Cxcl9), were upregulated. SAA3
is an acute-phase response protein and is upregulated by a
Table 5
Class prediction in three sets of randomized test samples using a subset of 14 predictive genes in blood
Test 1 Test 2 Test 3
Sample True value Prediction Sample True value Prediction Sample True value Prediction
21_blood Nonlethal Controla 23_blood Nonlethal Not predictedb 11_blood Control Control
25_blood Nonlethal Nonlethal 28_blood Nonlethal Nonlethal 12_blood Control Control
28_blood Nonlethal Nonlethal 31_blood Nonlethal Controla 18_blood Nonlethal Not predictedb
36_blood Lethal Lethal 42_blood Lethal Lethal 24_blood Nonlethal Nonlethal
37_blood Lethal Lethal 45_blood Lethal Lethal 29_blood Nonlethal Controla
39_blood Lethal Not predictedb 47_blood Lethal Lethal 36_blood Lethal Lethal
4_blood Control Control 4_blood Control Control 37_blood Lethal Lethal
6_blood Control Control 5_blood Control Control 38_blood Lethal Lethal
7_blood Control Control 8_blood Control Control 5_blood Control Control
8_blood Control Control 9_blood Control Control 9_blood Control Control
The true value refers to the known exposure, control, nonlethal, or lethal. The prediction value refers to the class to which the animal was predicted to belong,
based on the predictive gene set.
a Incorrect prediction.
b Not predicted because p value ratio >0.2.
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glucocorticoids [36,37]. SAA stimulates the rapid expres-
sion and release of tumor necrosis factor-a from cultured
human blood neutrophils and monocytes, suggesting a role
for SAA in cytokine production in acute inflammation and
immune responses [38]. Tgtp is a gene encoding a 47-kDa
protein in mouse peritoneal macrophages induced by IFN-
g [39]. This gene was strongly induced by endogenous
IFN-ah, suggesting that it might participate in defense
against viral infection [40]. Studies indicated that IFN-g
and interleukin-12 are key cytokines that induce type 1
immune responses in protection of the host against LM
infection [2]. C-X-C chemokines are major chemoattrac-
tants that direct granulocytes, natural killer cells, macro-
phages, and lymphocytes migrating into inflammatory sites
[41]. Many chemokines are induced by IFN-g [42]. The
upregulation of predictor genes Saa3, Tgtp, Ifi47, and
Cxcl9 is consistent with the functions of these genes in the
host immune or inflammatory process in response to viral
and bacterial invasions. The downregulation of the other
predictor genes, including an unknown RIKEN DNA
sequence, is less obvious, although it was found that
hepatic cytochrome p450 enzymes CYP1A, CYP2B, and
CYP3A were significantly lowered 48 and 72 h after
systemic infection with LM [43], and this may be due to
compromised hepatic function.
To validate the gene expression fold changes in micro-
array analysis, we employed a quantitative RT-PCR
technique using hybridization probes in PCR, which gives
specificity in measurement for the target amplification
products and eliminates background noise. Not only did
our RT-PCR results confirm that Tgtp and Saa3 were
upregulated and cytochrome P450 (Cyp17a1) was down-
regulated in the infected animals, but also the fold changes
in expression levels were generally consistent. The RT-PCR
showed a 1.4- and a 1.94-fold increase in Tgtp and Saa3,
respectively, in the nonlethal group, which was not apparent
in microarray analysis. This may be attributable to the meanvalue of different numbers of animals being used in the two
analyses and/or the quantitative RT-PCR using hybridization
probes in detection format being more sensitive and specific
at low levels and for small changes in mRNA levels.
Development of clinically relevant and sensitive surro-
gate markers of responses to the infectious agents prior to
overt clinical toxicity is important. Our results indicated that
using 14 genes from blood samples allows assignment of
unknown samples to the control, nonlethal, or lethal group
of LM infection with about 80% accuracy and thus may
provide hope in finding surrogates for prediction of clinical
outcomes; however, different genes were predictive in liver
and blood. Two of the blood predictor genes are ESTs or
without known function. The eosinophil-associated ribonu-
clease 1 (Ear1) gene was shown to play a role in host
defense against RNA virus pathogens [44]. Annexin A2 is a
member of the multifunctional annexin family of Ca2+-
dependent phospholipid binding proteins and has been
reported to be upregulated in virally transformed cell lines
[45]. The gene encoding insulin-like growth factor binding
protein 4 (Igfbp4) is involved in regulation of tumor cell
growth and was shown to be differentially expressed in
astrocytoma progression [46]. This gene was also identified
as one of the predictor genes that can differentiate
hepatoblastoma tumor from nondiseased liver according to
their gene expression profiles [47]. CD48 is a cell surface
protein and a critical mediator of activation of mast cells
following exposure to mycobacteria [48]. Other predictor
genes may be involved in signal transduction, cell cycle
regulation, and apoptosis (such as Bcl2a1a); however, the
biological functions of these genes with regard to host
response to LM infection are not clear. The relative
importance and specific functions of the genes in the
clearance of LM infection treated with antibiotics are
currently under investigation in our laboratory.
We do not think, at this stage, that these predictor genes
are specific for LM infection. There may also be differ-
ences in the host response gene expression between mouse,
H.H. Ng et al. / Genomics 86 (2005) 657–667664which is permissive for listeriosis, and human, in which
infection with LM is relatively innocuous in healthy
people, but causes more severe effects in immunocompro-
mised individuals. The predictor genes in the mouse model
will therefore not necessarily be predictive in humans;
however, given the fact that these genes represent broad
response genes for stress and inflammation, it seems
reasonable to assume that the same or similar genes will
be relevant in human listeriosis. Further studies with a
larger sample size may help to validate the predictive gene
expression profiles and explore fully the entire network of
the genes involved in the mechanism of response to LM
infection. We acknowledge the fact that for some com-
pounds or bioagents, the host response to the treatment may
be governed by mechanisms that are not readily revealed at
the transcriptional level (gene expression), such as post-
transcriptional regulation, posttranslational modification,
proteasome function, or protein-protein interactions. We
are also aware that there is discordance between different
array platforms, and standardization requires cooperation
across industry, academia, and medicine, as well as across
international borders [49].
Nevertheless, the present study shows that microarray
analysis of host gene expression in response to pathogen
infection provides a powerful approach to explore the
expression of a large set of genes, which is important to
understand the interaction between a pathogen and the host
and pathogenesis. In addition, microarrays provide a
tremendous amount of information that helps find expres-
sion patterns from different levels of exposure of LM and
predict/classify unknown samples. Gene expression profil-
ing in host blood using microarray and rapid PCR-based
gene expression profiling in validation may be able to serve
as a surrogate for toxicity outcome. This knowledge may
ultimately contribute to the design of treatments for
infectious disease, therapeutic development, and vaccination
strategies.Materials and methods
Animal treatment and sample collection
Female BALB/c mice (Charles River Laboratories)
approximately 6–8 weeks of age were maintained on
Purina Certified Rodent Chow 5002 (Richmond, IN,
USA) and purified tap water ad libitum in microisolator
cages under controlled lighting (12-h light-dark cycle).
Animals were randomly assigned to dose groups and then
administered, via intravenous tail injection, medium broth
(control) or 9.8  102 to 2  103 CFU (nonlethal dose) or
5.3  104 to 7  104 CFU (lethal dose) of LM. Blood was
collected via retro-orbital sinus and stored in PAXgene
(Qiagen, Valencia, CA, USA) until RNA extraction. A
section of liver was collected to quantify CFU of LM in
liver for determination of pathogen burden, and a section ofliver was collected in phosphate-buffered 10% formalin for
histopathology. The remaining portions of liver were stored
in RNAlater (Qiagen) at 70-C until processed for RNA
extraction.
Infection burden determination
At necropsy, the left lobe of the liver was weighed and
placed in a 5-ml homogenizing tube kept on ice. Saline (1
ml) was added to the tube and the tissue was homogenized
using a Polytron homogenizer. The homogenate was diluted
as necessary and a 100-Al aliquot was plated (in duplicate)
onto trypticase soy agar plates with 5% sheep blood
(Becton–Dickinson, Sparks, MD, USA). The plates were
incubated at 37-C for ¨24 h, then bacterial plaques were
counted and the infectious burden calculated as CFU/mg
liver (average of four to six animals).
Histopathological analysis
The formalin-fixed liver samples were embedded in
paraffin, cut approximately 5 Am thick, and stained with
hematoxylin and eosin. Histopathologic examination was
performed by a board-certified veterinary pathologist.
RNA isolation
Total RNAwas extracted using the RNeasy kit (Qiagen).
RNA quality was assessed by ethidium bromide agarose gel
electrophoresis. Concentration was determined at 260 nm
absorbance by a spectrophotometer.
Sample preparation for microarray hybridization and
analysis
Total RNA was used to prepare labeled cRNA target for
analysis on microarray according to the standard protocols
from Affymetrix. Briefly, cDNA was synthesized from total
RNA in the presence of T7-(dT)24 oligomer, using the
Superscript kit (Invitrogen, Carlsbad, CA, USA). The cRNA
was prepared using biotin-labeled nucleotides in the ENZO
Bioarray HighYield RNA Transcript Labeling Kit (Enzo
Diagnostics, Farmingdale, NY, USA), then purified, quanti-
fied using spectrophotometric analysis, and checked by gel
electrophoresis. The cRNA was fragmented using a frag-
mentation buffer and heat. The labeled cRNA was then
added to a hybridization solution, hybridized to Murine
Genome U74Av2 Arrays (MG-U74Av2) (Affymetrix, Santa
Clara, CA, USA), and incubated at 45-C for 16 h. Following
the hybridization step, the hybridized probe was washed and
stained and then scanned to acquire an image of each probe.
The image was analyzed for expression intensity using
Affymetrix analysis software, Microarray Suite 5.0, and
GeneSpring software (Silicon Genetics, Redwood City, CA,
USA). Quality checks of the microarray screening included
confirmation of complete cDNA synthesis of housekeeping
H.H. Ng et al. / Genomics 86 (2005) 657–667 665genes, positive detection of spiked control, and low and
consistent background noise levels.
Microarray data analysis
Analysis of the data to find ‘‘interesting’’ genes involves
first preprocessing the raw data for quality control, includ-
ing standardization of the data (i.e., normalization to make
the data uniformly comparable throughout the dataset), and
filtering the data to eliminate genes with low precision, large
error values, or expression levels that are too close to the
background, based on the behaviors of the genes in
experiments.
Experimental normalization
Global normalization was performed to standardize
samples by minimizing nonbiological processing variation
so that relative gene expression levels could be compared.
We assumed that most of the genes were not changed
across the GeneChips. Normalization was performed
according to the suggested default procedures in the
GeneSpring software.
Gene filters for quality control
We applied filters to retain only qualified genes that
were ‘‘Present’’ or ‘‘Marginal’’ in the GeneChips. In
blood sample analysis, since only about 10–15% of the
total 12,422 mouse genes in the GeneChip were
‘‘Present’’ in the blood, we selected only genes with
expression levels between treatment groups (control,
nonlethal, and lethal) that were statistically significant
(one-way ANOVA, p  0.05).
Class prediction
We used a supervised learning method (K-nearest
neighbor) in which the algorithm learns from samples with
known class membership (Training Set) and establishes a
prediction rule to classify independent new samples (Test
Set). First, the transcription profiles of the animals in the
control, nonlethal, or lethal group were used to identify
genes with high predictive power for discerning groups by
identifying idealized expression patterns associated with a
given class. Following the identification, a ‘‘neighborhood
analysis’’ was performed, in which the number of genes
correlated to an idealized expression pattern was counted
and the results were compared with a randomly generated
pattern. A p value was calculated for the likelihood of
observed representation of each class. The class with the
smallest p value was compared to the class with the second
smallest p value ( p value ratio), and a prediction was made
if the p value ratio was <0.2.
Hierarchical clustering
A centroid-clustering method was used to calculate the
profiles representing a binary subtree of samples in the
similarity search. The algorithm first found the two mostcorrelated gene expression profiles and grouped them under
one subtree. Then, it found the pair of the subtree that was
the next most correlated and grouped that pair under one
branch. This process was repeated until all the genes were
merged into one large tree.
Validation of predictive gene expression by real-time
RT-PCR
Real-time RT-PCR was performed in a two-step process.
In the first step, the single stranded cDNA was synthesized
from total RNA using SuperScript II RNase H reverse
transcriptase (Invitrogen). In the second step, quantitative
measurement of target transcript in each animal sample was
achieved using a LightCycler with FastStart DNA Master
Hybridization Probes (Roche, Indianapolis, IN, USA). The
use of hybridization probes in PCR gives specificity in
measurement for the target amplification products and
eliminates background noise. The thermal cycling condi-
tions for PCR were initial denaturation for 10 min at 95-C,
followed by 50 cycles of 95-C for 15 s, annealing at 55-C
for 10 s, extension at 72-C for 15 s, and fluorescent data
acquisition at 55-C. A standard curve for each primer pair
was created in each PCR run by using four to seven serially
diluted reference cDNA samples from a control animal.
Gene-specific primers for real-time PCR corresponding to
the genes present on the Affymetrix GeneChip were
designed and synthesized (TIB MolBio LLC, Adelphia,
NJ, USA). The following primers were used: mouse T-cell-
specific GTPase (mTGTP), forward 5V-GAAGTGT-
TATTGCCACCAGATC-3V and reverse 5V-GCACTCTC-
GATGTCTCTCAGTA; mouse serum amyloid A3 protein
(SAA3), forward 5V-AAGAAGCTGGTCAAGGGTCT and
reverse 5V-CTCTCTGGCATCGCTGATG; cytochrome
P450, 17 (CYP17), forward 5V-CGGTTTATGCCTGAGCG
and reverse 5V-CGATCAGAAAGACCACCTTG; and
mouse GAPDH, forward 5V-ATTCAACGGCACAGT-
CAAGG and reverse 5V-TGGATGCAGGGATGATGTTC-
3V. GAPDH was amplified by using the same target cDNA
as a control to normalize the expression levels of the genes.
In preparation of cDNA, the total RNA was from the same
animal but in different extractions, and therefore, they were
parallel but independent processes. For RT-PCR analysis,
duplicate PCRs were carried out for each cDNA sample, and
the cDNA of three to four animals from each treatment
group was used in the RT-PCR confirmation.Acknowledgments
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